Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New strategies are being evaluated for people with nonresponsive or relapsing disease.
Safety profile suggests patients receiving the new immunotherapy may not need to be hospitalized.
This approach has the potential to challenge the way cancer research is usually now done, one body part at a time.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.